Depression 5 - Clinical (3)

[P435] Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial

*Yohei Ohtani¹, Hideaki Tani¹, Kie Nomoto-Takahashi¹, Taisuke Yatomi¹, Kengo Yonezawa¹, Sota Tomiyama¹, Nobuhiro Nagai³, Keisuke Kusudo¹, Shiori Honda¹, Shinichiro Nakajima¹, Tsuyoshi Eiro², Tomoyuki Miyazaki², Takuya Takahashi², Hiroyuki Uchida¹ (1. Keio University School of Medicine, 2. Yokohama City University Graduate School of Medicine, 3. Minami-Hanno Hospital)

Keywords:Antidepressant, Ethnicity, Ketamine, Major depressive disorder, Treatment-resistant depression